Meta-analysis of SATB2 immunohistochemical expression in colorectal cancer versus primary ovarian mucinous neoplasms

Ann Diagn Pathol. 2024 Aug:71:152302. doi: 10.1016/j.anndiagpath.2024.152302. Epub 2024 Apr 16.

Abstract

Background: Reliably distinguishing primary ovarian mucinous neoplasms (POMNs) from metastatic colorectal cancers (CRCs) is both challenging to the histopathologist and of great clinical importance. Special AT-rich sequence binding protein-2 (SATB2) has emerged as a useful diagnostic immunohistochemical marker of colorectal cancer. This meta-analysis compares SATB2 expression in POMNs and CRC.

Methods: A systematic literature search for relevant studies was conducted. Meta-analysis of SATB2 positivity was undertaken using a random effects model.

Results: Seven studies including 711 CRCs and 528 POMNs were included. SATB2 positivity was seen in 81 % (95 % CI: 72-88 %) of CRCs and 4 % (95 % CI: 1-11 %) of POMNs. Variation was seen in immunohistochemical methods used for SATB2 detection and threshold for positivity.

Conclusion: SATB2 staining remains high in CRC and low in POMNs, supporting its use in differentiating these two pathologies with vastly differing prognosis and treatment.

Keywords: Colorectal cancer; Immunohistochemistry; Primary ovarian mucinous neoplasms; SATB2.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Adenocarcinoma, Mucinous* / diagnosis
  • Adenocarcinoma, Mucinous* / metabolism
  • Adenocarcinoma, Mucinous* / pathology
  • Biomarkers, Tumor* / analysis
  • Biomarkers, Tumor* / metabolism
  • Colorectal Neoplasms* / diagnosis
  • Colorectal Neoplasms* / metabolism
  • Colorectal Neoplasms* / pathology
  • Diagnosis, Differential
  • Female
  • Humans
  • Immunohistochemistry* / methods
  • Matrix Attachment Region Binding Proteins* / metabolism
  • Ovarian Neoplasms* / diagnosis
  • Ovarian Neoplasms* / metabolism
  • Ovarian Neoplasms* / pathology
  • Transcription Factors* / metabolism

Substances

  • Matrix Attachment Region Binding Proteins
  • SATB2 protein, human
  • Biomarkers, Tumor
  • Transcription Factors